Felix Rosenow

Felix Rosenow is an expert in Neurology at University Hospital Frankfurt (Germany). As of October 2026, ScienceLeadR ranks Felix Rosenow in the top 1% of experts worldwide for Seizures, Epilepsy and Epidemiologic Studies. Felix Rosenow has authored 638 publications, the most recent in 2026, and is an investigator in 13 clinical trials, 3 of them ongoing. SLR score: 1,882 (community average: 125). How the SLR is computed.

Neurology

Subspecialties: Public Health - Neurosurgery - Psychiatry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on October 7, 2026

Expert Rankings

Top experts on the MeSH terms this expert works on

Top Epidemiologic Studies key opinion leaders

Organizations

Career arc: 1995 - 2026

Source: PubMed

Goethe University Frankfurt

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 638

Citations

Citations: 26 121 1st author: 53 Last author: 115 Unique author: 4

Main journals

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title	Journal	Year	Citations
Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study. PMID 42586099 — registries, pregnancy, lamotrigine, growth, cohort studies, gestational age, levetiracetam, birth weight, nervous system, carbamazepine, valproic acid	Lancet Neurol Top journal	2026	2
Hippocampal network activity changes during early epileptogenesis predict subsequent epilepsy. PMID 42470656 — epilepsy, perforant pathway, seizures	Epilepsia	2026	0
Cost of waiting: association of EEG delay and poor functional outcome in adult status epilepticus. PMID 42448462 — mortality, seizures, diagnosis, neurology, status epilepticus	J Neurol Neurosurg Psychiatry	2026	1
Reliability of EEG in brain death diagnosis: an analysis of clinical and technical factors. PMID 42292231 — reading, resuscitation, brain, electroencephalography, brain death, diagnosis	Front Med (Lausanne)	2026	0
Autoimmune encephalitis-associated epilepsy with glutamic acid decarboxylase autoantibodies and type 1 diabetes mellitus: A comprehensive systematic scoping review of a clinical syndrome. PMID 42173229 — diabetes mellitus, glutamate decarboxylase, autoantibodies, epilepsy, seizures, carboxy-lyases, therapeutics, glutamic acid, encephalitis, diabetes mellitus, type 1	Autoimmun Rev	2026	0

Clinical Studies 13

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 6

Phase 2 4

N/A 3

By status:

Completed 7

Recruiting 3

Active not recruiting 2

Unknown 1

By type:

Interventional 11

Observational 2

By Monocentric/Multicentric:

monocentric 2

multicentric2to4 1

multicentric5to9 0

multicentricup10 10

Main Topics

Nervous System Diseases 8

Cohort/Consortium Investigators 16

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study	Phase	Status	Start
Randomized Study of XEN1101 Versus Placebo in Focal Onset Seizures (X TOLE3) 2022-502281-25-00 — safety, seizures, therapeutics	Phase 3	Active not recruiting	2023
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy 2025-521640-38-00 — epilepsy, seizures	Phase 3	Recruiting	2025
Sustained Effort Network for Treatment of Status Epilepticus European Academy of Neurology Registry on Refractory Status Epilepticus (SENSE II AROUSE) NCT05839418 — registries, therapeutics, physical exertion, neurology, status epilepticus	N/A	Recruiting	2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS

Shopping Cart

System Maintenance Notice